Evaluating the Risk-Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review
Pharmacy (Basel). 2024 Aug 22;12(4):129. doi: 10.3390/pharmacy12040129. ABSTRACT BACKGROUND: The 2019 coronavirus (COVID-19) outbreak was declared a global pandemic in March 2020. It quickly spread …